TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $38,397,000 | -14.9% | 578,000 | 0.0% | 0.51% | -16.5% |
Q2 2021 | $45,096,000 | -5.6% | 578,000 | +14.5% | 0.61% | -14.4% |
Q1 2021 | $47,768,000 | -32.8% | 505,000 | -13.4% | 0.71% | -35.0% |
Q4 2020 | $71,039,000 | +112.3% | 583,000 | +52.2% | 1.09% | +66.3% |
Q3 2020 | $33,459,000 | +35.3% | 383,000 | 0.0% | 0.66% | +21.7% |
Q2 2020 | $24,738,000 | – | 383,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |